BioRestorative Therapies, Inc. has announced a stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $2 million of its common stock until June 16, 2026.

Blue Foundry Bancorp has announced its sixth stock repurchase program, authorizing the buyback of up to 1,082,533 shares of its common stock, representing about 5% of its outstanding shares. This ...

On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is ...

Brown-Forman initiated a $400 million share buyback program in early October, but the program may not be an accretive use of capital. The company's growth outlook is concerning; secular trends in ...

Lemonade (NYSE:LMND) said Monday it is in the process of renewing its reinsurance program, having decided to reduce the ceded proportion of its quota share reinsurance from ~55% to ~20%, effective ...

ALT5 Sigma Corporation (NASDAQ: ALTS) (FRA:5AR1) (“ALT5” or the “Company”), a fintech company focused on digital asset infrastructure and blockchain-enabled solutions, today announced that its Board ...

Palantir rose after the Pentagon designated its Maven AI platform a program of record, while a new U.K. regulatory trial highlights potential expansion beyond defense into commercial applications.